NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc. announced today that the Company’s broad pipeline of antibiotic candidates will be featured in 17 posters and presentations at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), taking place September 17-20, 2011 in Chicago, IL. Rib-X’s RX-04 program for the treatment of drug resistant Gram-negative and Gram-positive pathogens will be featured in 14 posters and an invited oral summary session. Rib-X’s clinical-stage candidates, delafloxacin and radezolid, will also be featured in poster presentations.
